307353-95-3Relevant articles and documents
HETEROCYCLIC INHIBITORS OF TYROSINE KINASE
-
Paragraph 0479, (2020/11/03)
The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of HER2 or EGFR for the treatment or prevention of disease, including cancer.
Substituted quinolines as antitumor agents
-
, (2008/06/13)
The invention provides a compound of Formula (Ia), or a pharmaceutically acceptable salt. prodrug or solvate thereof. The invention also provides a process for the preparation of a compound of Formula (Ia), pharmaceutical compositions of a compound of Formula (Ia) and methods for the treatment or prevention of cancer comprising administering an effective amount of a compound of Formula (Ia).